Development of Furanopyrimidine-Based Orally Active Third-Generation EGFR Inhibitors for the Treatment of Non-Small Cell Lung Cancer | Journal of Medicinal Chemistry
ΒΑΣΗ ΜΠΟΥΚΑΛΙΟΥ ΠΟΔΗΛΑΤΟΥ 6 mm (De Lux) - easy - market . gr
Discovery of 1-{(3R,4R)-3-[({5-Chloro-2-[(1-methyl-1H-pyrazol-4-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl}oxy)methyl]-4-methoxypyrrolidin-1-yl}prop-2-en-1-one (PF-06459988), a Potent, WT Sparing, Irreversible Inhibitor of T790M-Containing EGFR Mutants ...
ΒΑΣΗ ΜΠΟΥΚΑΛΙΟΥ ΠΟΔΗΛΑΤΟΥ 6 mm (De Lux) - easy - market . gr